Reduction of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant infection by blocking the epidermal growth factor receptor (EGFR) pathway

ABSTRACT The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants presents challenges in global efforts to transition from the pandemic to an endemic stage. The spike protein of the SARS-CoV-2 virus, which is pivotal for cell entry, exhibits significant mutations in its...

Descripció completa

Dades bibliogràfiques

Autors principals:	Yeonju Han, Seunghwan Kim, Taehyun Park, Hyemin Hwang, Sanghee Park, Jimin Kim, Jae-chul Pyun, Misu Lee
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology 2024-11-01
Col·lecció:	Microbiology Spectrum
Matèries:	SARS-CoV-2 variants spike protein mutations EGFR pathway osimertinib antiviral therapy
Accés en línia:	https://journals.asm.org/doi/10.1128/spectrum.01583-24
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!